Kadınlarda Kontraseptif Yöntemler
Özet
Temel sağlık hizmetleri arasında yer alan doğurganlığın düzenlenmesi yoksulluğun azaltılması, kadınların güçlendirilmesi ve sürdürülebilir kalkınmanın gerçekleştirilmesinin temelini oluşturmaktadır. Kadınların üreme yaşamları boyunca istedikleri kontraseptifi bilinçli olarak seçmesi ve seçtikleri kontraseptife devam etmesi anne ve çocuk sağlığı için oldukça önemlidir. Bu bölümde kadına yönelik kontraseptif yöntemler; hormonal kontraseptif yöntemler, rahim içi araçlar, bariyer kontraseptifler ve gönüllü cerrahi sterilizasyon başlıkları altında ele alınmıştır.
Referanslar
Alfred, S., Brody, S. A., & Barrett-Mitchell, J. (2020). The renaissance of hormone-free barrier contraception and development of FemCap™: hormone-free contraception. Gynecol Reprod Health, 4 (4), 1-6.
Alton, K., & Jensen, J. (2018). Update on permanent contraception for women. Current Obstet- rics and Gynecology Reports, 7(4), 163-171.
Bahamondes, L., Fernandes, A., Monteiro, I., & Bahamondes, M. V. (2019). Long-acting re- versible contraceptive (LARCs) methods. Best Practice & Research Clinical Obstetrics & Gynaecology. 66, 28-40.
Beksinska, M., Wong, R., & Smit, J. (2020). Male and female condoms: Their key role in preg- nancy and STI/HIV prevention. Best Practice & Research Clinical Obstetrics & Gynaeco- logy, 66, 55-67.
Britton, L. E., Alspaugh, A., Greene, M. Z., & McLemore, M. R. (2020). An evidence-based update on contraception: a detailed review of hormonal and nonhormonal methods. The American Journal of Nursing, 120(2), 22-23.
Cahill, E. P., & Kaur, S. (2020). Advances in contraception research and development. Current Opinion in Obstetrics and Gynecology, 32(6), 393-398.
Chen, B.A., Blithe, D.L., Muraguri, G.R., Lance, A.A., Carr, B.R., Jensen, & Burke, A.,E. (2019). Acceptability of the woman’s condom in a phase III multicenter open-label study. Contra- ception, 99:357–362.
Cipriani, S., Todisco, T., Scavello, I., Di Stasi, V., Maseroli, E., & Vignozzi, L. (2020). Obesity and hormonal contraception: an overview and a clinician’s practical guide. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 25(5), 1129-1140.
Coleman, J. E., Bongers, M., Veersema, S., Thurkow, A., & Gannon, M. J. (2017). Development and ınitial clinical experience with AltaSeal®: a novel hysteroscopically placed permanent contraception system. Current Obstetrics and Gynecology Reports, 6(1), 74-81.
Colquitt, C. W., & Martin, T. S. (2017). Contraceptive methods: A review of nonbarrier and barrier products. Journal of Pharmacy Practice, 30(1), 130-135.
Cordero-Franco, C. (2019). Reviving permanent contraception: New medical procedures or new service delivery modalities? Best Practice & Research Clinical Obstetrics & Gynaeco- logy, 66, 15-27.
Çal A, Ölçer Z. Doğurganlığın Düzenlenmesi. 1.Baskı, Vize Yayıncılık, 2021.
Duijkers, I., Klipping, C., Kinet, V., Jost, M., Bastidas, A., & Foidart, J. M. (2021). Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function. Contracepti- on, 103(6), 386-393.
Ferreira-Filho, E. S., de Melo, N. R., Sorpreso, I. C. E., Bahamondes, L., Simões, R. D. S., Soa- res-Júnior, J. M., & Baracat, E. C. (2020). Contraception and reproductive planning during the COVID-19 pandemic. Expert Review of Clinical Pharmacology, 13(6), 615-622.
Festin, M. P. R. (2020). Overview of modern contraception. Best Practice & Research Clinical Obstetrics & Gynaecology, 66, 4-14.
Gemzell-Danielsson, K., Kubba, A., Caetano, C., Faustmann, T., Lukkari-Lax, E., & Heikinhei- mo, O. (2021). Thirty years of mirena: A story of innovation and change in women’s healt- hcare. Acta Obstetricia et Gynecologica Scandinavica, 100(4), 614-618.
Giovanni Grandi, Fabio Barra, Simone Ferrero & Fabio Facchinetti (2019) Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism, 14:3,153-155.
Jalalvandi, E., Jafari, H., Amorim, C. A., Petri, D. F. S., Nie, L., & Shavandi, A. (2021). Vaginal administration of contraceptives. Scientia Pharmaceutica, 89(1), 3.
Johnston, D. S., & Goldberg, E. (2020). Preclinical contraceptive development for men and wo- men. Biology of Reproduction, 103(2), 147-156.
Kumar, S., Hota, S., Pais, R., Das, K., Santra, T., & Misra, S. (2021). Implications of advance bi- omaterials in development of new contraceptive devices. Journal of Materials NanoScience, 8(1), 23-34.
Kendall, E., & Lebari, D. (2019). Barrier contraception methods. InnovAiT, 12(6), 332-337. Kolawole, O. O., Sowemimo, O. O., Ojo, O. O., & Fasubaa, O. B. (2018). Contraceptive implants:
A review and current perspective in southwest Nigeria. Tropical Journal of Obstetrics and Gynaecology, 35(2), 108-112.
Lee, Y., Li, W., Tang, J., Schwendeman, S. P., & Prausnitz, M. R. (2021). Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin. Journal of Controlled Release, 337, 676-685.
Mofidfa, M., O’Farrell, L., & Prausnitz, M. R. (2019). Pharmaceutical jewelry: Earring patch for transdermal delivery of contraceptive hormone. Journal of Controlled Release, 301, 140-145.
Nelson, A. L. (2018). An overview of properties of Amphora (Acidform) contraceptive vaginal gel. Expert Opinion on Drug Safety, 17(9), 935-943.
Nelson, A. L. (2021). The new low-dose transdermal contraceptive system (Twirla®): results from preclinical and Phase III trials. Therapeutic Delivery, 12(7), 501-514.
Nelson A. L. (2019). Comprehensive overview of the recently FDA-approved contracepti- ve vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, pa- tient controlled, reversible birth control method, Expert Review of Clinical Pharmaco- logy,12(10),953-963.
Palacios, S., Regidor, P. A., Colli, E., Skouby, S. O., Apter, D., Roemer, T., ... & Bitzer, J. (2020). Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a re- view of the literature. The European Journal of Contraception & Reproductive Health Care, 25(3), 221-227.
Pfitzer, A., Lathrop, E., Bodenheimer, A., RamaRao, S., Christofield, M., MacDonald, P., ... & Mikulich, M. (2020). Opportunities and challenges of delivering postabortion care and postpartum family planning during the COVID-19 pandemic. Global Health: Science and Practice, 8(3), 335-343.
Regidor, P. A. (2018). The clinical relevance of progestogens in hormonal contraception: Present status and future developments. Oncotarget, 9(77), 34628.
Regidor, P. A., Sailer, M., Calvo, E., Colli, E., Palacios, S., & Roemer, T. (2020). Improvement of dysmenorrhea, menstrual bleeding and continuation rate in women using the new vaginal ring Ornibel®. European Gynecology and Obstetrics, 2(2):127-131.
Ridgeway, K., Montgomery, E. T., Smith, K., Torjesen, K., van der Straten, A., Achilles, S. L., & Griffin, J. B. (2022). Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception. 106, 16-33.
Sivasankaran, S., & Jonnalagadda, S. (2021). Advances in controlled release hormonal techno- logies for contraception: A review of existing devices, underlying mechanisms, and future directions. Journal of Controlled Release, 330, 797-811.
Stuart, G. S., & Ramesh, S. S. (2018). Interval female sterilization. Obstetrics & Gynecology, 131(1), 117-124.
Teal, S., & Edelman, A. (2021). Contraception selection, effectiveness, and adverse effects: A Review. JAMA, 326(24), 2507-2518.
United Nations Department of Economic and Social Affairs, Population Division (2020). World Fertility and Family Planning 2020: Highlights https://www.un.org/en/development/desa/ population/publications/pdf/family/World_Fertility_and_Family_Planning_2020_Highli- ghts.pdf https://doi.org/
United Nations Department of Economic and Social Affairs, Population Division (2020). World Family Planning 2020 Highlights: Accelerating action to ensure universal access to family planning.https://www.un.org/development/desa/pd/sites/www.un.org.development.desa. pd/files/files/documents/2020/Sep/unpd_2020_worldfamilyplanning_highlights.pdf
Word Health Organization. Contraception. https://www.who.int/news-room/fact-sheets/detail/ family-planning-contraception.
World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Prog- rams (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Pro- viders (2018 update). Baltimore and Geneva: CCP and WHO, 2018
Wildemeersch, D., Andrade, A., Goldstuck, N. D., Hasskamp, T., & Jackers, G. (2017). Intra- uterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience. International Journal of Women’s Health, 9, 49-58.
Yilmaz, N., & Buyuk, G. N. (2021). COVİD-19 Pandemisinde kontrasepsiyon ve yeni jeneras- yon sadece progestin içeren hapların yeri. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 18(1), 746-750.
Referanslar
Alfred, S., Brody, S. A., & Barrett-Mitchell, J. (2020). The renaissance of hormone-free barrier contraception and development of FemCap™: hormone-free contraception. Gynecol Reprod Health, 4 (4), 1-6.
Alton, K., & Jensen, J. (2018). Update on permanent contraception for women. Current Obstet- rics and Gynecology Reports, 7(4), 163-171.
Bahamondes, L., Fernandes, A., Monteiro, I., & Bahamondes, M. V. (2019). Long-acting re- versible contraceptive (LARCs) methods. Best Practice & Research Clinical Obstetrics & Gynaecology. 66, 28-40.
Beksinska, M., Wong, R., & Smit, J. (2020). Male and female condoms: Their key role in preg- nancy and STI/HIV prevention. Best Practice & Research Clinical Obstetrics & Gynaeco- logy, 66, 55-67.
Britton, L. E., Alspaugh, A., Greene, M. Z., & McLemore, M. R. (2020). An evidence-based update on contraception: a detailed review of hormonal and nonhormonal methods. The American Journal of Nursing, 120(2), 22-23.
Cahill, E. P., & Kaur, S. (2020). Advances in contraception research and development. Current Opinion in Obstetrics and Gynecology, 32(6), 393-398.
Chen, B.A., Blithe, D.L., Muraguri, G.R., Lance, A.A., Carr, B.R., Jensen, & Burke, A.,E. (2019). Acceptability of the woman’s condom in a phase III multicenter open-label study. Contra- ception, 99:357–362.
Cipriani, S., Todisco, T., Scavello, I., Di Stasi, V., Maseroli, E., & Vignozzi, L. (2020). Obesity and hormonal contraception: an overview and a clinician’s practical guide. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 25(5), 1129-1140.
Coleman, J. E., Bongers, M., Veersema, S., Thurkow, A., & Gannon, M. J. (2017). Development and ınitial clinical experience with AltaSeal®: a novel hysteroscopically placed permanent contraception system. Current Obstetrics and Gynecology Reports, 6(1), 74-81.
Colquitt, C. W., & Martin, T. S. (2017). Contraceptive methods: A review of nonbarrier and barrier products. Journal of Pharmacy Practice, 30(1), 130-135.
Cordero-Franco, C. (2019). Reviving permanent contraception: New medical procedures or new service delivery modalities? Best Practice & Research Clinical Obstetrics & Gynaeco- logy, 66, 15-27.
Çal A, Ölçer Z. Doğurganlığın Düzenlenmesi. 1.Baskı, Vize Yayıncılık, 2021.
Duijkers, I., Klipping, C., Kinet, V., Jost, M., Bastidas, A., & Foidart, J. M. (2021). Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function. Contracepti- on, 103(6), 386-393.
Ferreira-Filho, E. S., de Melo, N. R., Sorpreso, I. C. E., Bahamondes, L., Simões, R. D. S., Soa- res-Júnior, J. M., & Baracat, E. C. (2020). Contraception and reproductive planning during the COVID-19 pandemic. Expert Review of Clinical Pharmacology, 13(6), 615-622.
Festin, M. P. R. (2020). Overview of modern contraception. Best Practice & Research Clinical Obstetrics & Gynaecology, 66, 4-14.
Gemzell-Danielsson, K., Kubba, A., Caetano, C., Faustmann, T., Lukkari-Lax, E., & Heikinhei- mo, O. (2021). Thirty years of mirena: A story of innovation and change in women’s healt- hcare. Acta Obstetricia et Gynecologica Scandinavica, 100(4), 614-618.
Giovanni Grandi, Fabio Barra, Simone Ferrero & Fabio Facchinetti (2019) Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism, 14:3,153-155.
Jalalvandi, E., Jafari, H., Amorim, C. A., Petri, D. F. S., Nie, L., & Shavandi, A. (2021). Vaginal administration of contraceptives. Scientia Pharmaceutica, 89(1), 3.
Johnston, D. S., & Goldberg, E. (2020). Preclinical contraceptive development for men and wo- men. Biology of Reproduction, 103(2), 147-156.
Kumar, S., Hota, S., Pais, R., Das, K., Santra, T., & Misra, S. (2021). Implications of advance bi- omaterials in development of new contraceptive devices. Journal of Materials NanoScience, 8(1), 23-34.
Kendall, E., & Lebari, D. (2019). Barrier contraception methods. InnovAiT, 12(6), 332-337. Kolawole, O. O., Sowemimo, O. O., Ojo, O. O., & Fasubaa, O. B. (2018). Contraceptive implants:
A review and current perspective in southwest Nigeria. Tropical Journal of Obstetrics and Gynaecology, 35(2), 108-112.
Lee, Y., Li, W., Tang, J., Schwendeman, S. P., & Prausnitz, M. R. (2021). Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin. Journal of Controlled Release, 337, 676-685.
Mofidfa, M., O’Farrell, L., & Prausnitz, M. R. (2019). Pharmaceutical jewelry: Earring patch for transdermal delivery of contraceptive hormone. Journal of Controlled Release, 301, 140-145.
Nelson, A. L. (2018). An overview of properties of Amphora (Acidform) contraceptive vaginal gel. Expert Opinion on Drug Safety, 17(9), 935-943.
Nelson, A. L. (2021). The new low-dose transdermal contraceptive system (Twirla®): results from preclinical and Phase III trials. Therapeutic Delivery, 12(7), 501-514.
Nelson A. L. (2019). Comprehensive overview of the recently FDA-approved contracepti- ve vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, pa- tient controlled, reversible birth control method, Expert Review of Clinical Pharmaco- logy,12(10),953-963.
Palacios, S., Regidor, P. A., Colli, E., Skouby, S. O., Apter, D., Roemer, T., ... & Bitzer, J. (2020). Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a re- view of the literature. The European Journal of Contraception & Reproductive Health Care, 25(3), 221-227.
Pfitzer, A., Lathrop, E., Bodenheimer, A., RamaRao, S., Christofield, M., MacDonald, P., ... & Mikulich, M. (2020). Opportunities and challenges of delivering postabortion care and postpartum family planning during the COVID-19 pandemic. Global Health: Science and Practice, 8(3), 335-343.
Regidor, P. A. (2018). The clinical relevance of progestogens in hormonal contraception: Present status and future developments. Oncotarget, 9(77), 34628.
Regidor, P. A., Sailer, M., Calvo, E., Colli, E., Palacios, S., & Roemer, T. (2020). Improvement of dysmenorrhea, menstrual bleeding and continuation rate in women using the new vaginal ring Ornibel®. European Gynecology and Obstetrics, 2(2):127-131.
Ridgeway, K., Montgomery, E. T., Smith, K., Torjesen, K., van der Straten, A., Achilles, S. L., & Griffin, J. B. (2022). Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception. 106, 16-33.
Sivasankaran, S., & Jonnalagadda, S. (2021). Advances in controlled release hormonal techno- logies for contraception: A review of existing devices, underlying mechanisms, and future directions. Journal of Controlled Release, 330, 797-811.
Stuart, G. S., & Ramesh, S. S. (2018). Interval female sterilization. Obstetrics & Gynecology, 131(1), 117-124.
Teal, S., & Edelman, A. (2021). Contraception selection, effectiveness, and adverse effects: A Review. JAMA, 326(24), 2507-2518.
United Nations Department of Economic and Social Affairs, Population Division (2020). World Fertility and Family Planning 2020: Highlights https://www.un.org/en/development/desa/ population/publications/pdf/family/World_Fertility_and_Family_Planning_2020_Highli- ghts.pdf https://doi.org/
United Nations Department of Economic and Social Affairs, Population Division (2020). World Family Planning 2020 Highlights: Accelerating action to ensure universal access to family planning.https://www.un.org/development/desa/pd/sites/www.un.org.development.desa. pd/files/files/documents/2020/Sep/unpd_2020_worldfamilyplanning_highlights.pdf
Word Health Organization. Contraception. https://www.who.int/news-room/fact-sheets/detail/ family-planning-contraception.
World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Prog- rams (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Pro- viders (2018 update). Baltimore and Geneva: CCP and WHO, 2018
Wildemeersch, D., Andrade, A., Goldstuck, N. D., Hasskamp, T., & Jackers, G. (2017). Intra- uterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience. International Journal of Women’s Health, 9, 49-58.
Yilmaz, N., & Buyuk, G. N. (2021). COVİD-19 Pandemisinde kontrasepsiyon ve yeni jeneras- yon sadece progestin içeren hapların yeri. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 18(1), 746-750.
